# Tamoxifen use and risk of endometrial cancer in breast cancer patients: A systematic review and dose–response meta‐analysis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/tamoxifen-use-and-risk-of-endometrial-cancer-in-breast-cancer-patients-a/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Matin Ghanavati,Yasaman Khorshidi,Mahdi Shadnoush,Mohammad Esmaeil Akbari,Seyed Hossein Ardehali,Yanin Chávarri-Guerra,Atieh Akbari,Regina Barragán-Carrillo,Manoochehr Amin Amlashi,Zeinab Javid,Jamal Rahmani |
| Citations | 37 |
| DOI | 10.1002/cnr2.1806 |
| Fields | Biochemistry, Genetics and Molecular Biology |
| Open Access | true |
| OA Status | gold |
| OA URL | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cnr2.1806 |
| OpenAlex ID | https://openalex.org/W4324129663 |
| PMID | 36916539 |
| Type | review |
| Year | 2023 |

## Paper authors

- [Matin Ghanavati](https://scholariq.org/researchers/matin-ghanavati/)

## Paper primary topic

- [Estrogen and related hormone effects](https://scholariq.org/topics/estrogen-and-related-hormone-effects/)

## Paper topics

- [Estrogen and related hormone effects](https://scholariq.org/topics/estrogen-and-related-hormone-effects/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [BRCA gene mutations in cancer](https://scholariq.org/topics/brca-gene-mutations-in-cancer/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.